Login to Your Account



Genentech Beats 4Q Estimates, Files To Expand Nutropin Label

By Aaron Lorenzo


Friday, January 16, 2004
Genentech Inc. released year-end and quarterly earnings that beat consensus estimates, simultaneously disclosing its application for an expanded indication of one of its growth hormone products. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription